Saturday, August 15, 2009

The UK Shows Concern Over Swine Flu (H1N1) Vaccine



A warning that the new swine flu jab is linked to a deadly nerve disease has been sent by the Government to senior neurologists in a confidential letter.

The letter from the Health Protection Agency, the official body that oversees public health, has been leaked to The Mail on Sunday, leading to demands to know why the information has not been given to the public before the vaccination of millions of people, including children, begins.

It tells the neurologists that they must be alert for an increase in a brain disorder called Guillain-Barre Syndrome (GBS), which could be triggered by the vaccine.

GBS attacks the lining of the nerves, causing paralysis and inability to breathe, and can be fatal.

The letter, sent to about 600 neurologists on July 29, is the first sign that there is concern at the highest levels that the vaccine itself could cause serious complications.



It refers to the use of a similar swine flu vaccine in the United States in 1976 when:

  • More people died from the vaccination than from swine flu.
  • 500 cases of GBS were detected.
  •  The vaccine may have increased the risk of contracting GBS by eight times.
  • The vaccine was withdrawn after just ten weeks when the link with GBS became clear.
  • The US Government was forced to pay out millions of dollars to those affected.


You can read more here.

Some questions:
-Does this hold merit or do you think it is just a scare tactic?
-Does this affect your opinion of getting the Swine Flu vaccine?
-If a senior neurologist would not get the vaccine would that affect your decision to get the vaccination?
-Did you know about the vaccination debacle that took place in the U.S. under Gerald Ford's presidency?

***** As a note to my readers, I don't intend on turning this blog into a blog about vaccinations. However, it is a topic that is very real to me and my family at this time and we are trying to work through it in a logical and ethical manner. *****

No comments: